Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.045
+0.005 (0.48%)
At close: Nov 7, 2024, 4:00 PM
1.031
-0.014 (-1.34%)
After-hours: Nov 7, 2024, 5:36 PM EST
Achilles Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
$2.83
Upside
+170.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $8 → $2 | Buy → Hold | Downgrades | $8 → $2 | +91.39% | Apr 5, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $6 | Strong Buy | Maintains | $11 → $6 | +474.16% | Apr 5, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $0.5 | Strong Buy → Sell | Downgrades | $7 → $0.5 | -52.15% | Dec 14, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +952.63% | Aug 7, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +952.63% | May 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +1,526.79% | Dec 7, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +665.55% | Dec 7, 2022 |
| JP Morgan | JP Morgan | Sell Initiates $11 | Sell | Initiates | $11 | +952.63% | Apr 26, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +2,483.73% | Apr 26, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates $25 | Buy | Initiates | $25 | +2,292.34% | Apr 26, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +2,100.96% | Apr 26, 2021 |